New patent for Astrazeneca Ab drug BYDUREON

Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from two suppliers. There are twenty patents…

The post New patent for Astrazeneca Ab drug BYDUREON appeared first on DrugPatentWatch Blog.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: